ZERIA PHARMACEUTICAL CO.,LTD.
TSE Prime
¥1,982.00
+0.00%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.65.
- Comfortable interest cover: operating profit covers interest about 24.7 times.
- Net profit margin is 9.5%.
- Profit has compounded about 21% a year over five years.
- Sales have compounded about 11% a year over five years.
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Return on equity is on the lower side at 8.5%.
- Return on capital employed is on the lower side at 10%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.48
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥874億
Current Price¥ 1,982.00
High / Low¥ 2,434.00 / 1,878.00
Stock P/E10.330449
Book Value¥ 2,459.12
Dividend Yield2.47%
ROCE9.98%
ROE8.50%
Debt to Equity0.65
Current Ratio1.48
P/B Ratio0.80864525
EPS¥ 191.80
PAT Margin9.48%
ICR24.66
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity